Conclusion: Theres No One-Size-Fits-All Winner Both Tirzepatide and Retatrutide represent major advances in metabolic medicine each with unique strengths
During your online consultation, your licensed provider will review your medical history, discuss your goals, and design a personalized GLP-1 treatment plan
however, those who persisted with the medication coverage experienced weight losses comparable with those shown in corresponding clinical trials. And in a paper published in 2023, researchers found that while significant weight loss was achievable with GLP-1s among type 2 diabetes patients, the average weight reduction was relatively modest, 2.2% after 72 weeks of being on the medications
Side effects The most common side effects include nausea, vomiting, and diarrhea, necessitating a slow titration of the dose to ensure tolerance
At 6 months, semaglutide reaches 10 to 14% while tirzepatide reaches 13 to 18%
12 Lower leptin levels are associated with a higher risk of weight gain over 2 years in healthy young adults, 29 whereas an increase in soluble leptin receptors has been associated with leptin resistance